Applicant, as named in the Orange Book

Chemocentryx

Next listed expiry: Tavneos on 27 Nov 2039. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Tavneos avacopan	avacopan	214487	27 Nov 2039	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.